Table 1.
Characteristics between the fetal death and fetal survival group.
| Total | Fetal death | Fetal survival | p-value | |
|---|---|---|---|---|
| Number | 90 | 28 (31.1%) | 62 (68.9%) | |
| Age | 29.2 ± 4.0 | 29.9 ± 4.5 | 29.0 ± 3.8 | 0.308# |
| BMI (kg/m2) | 24.9 ± 3.28 | 24.9 ± 2.7 | 24.9 ± 3.5 | 0.957# |
| Gestation weeks | 35.0 (26.4, 37.3) | 30.1 (26.4, 35.0) | 36.1 (31.7, 37.6) | 0.002a |
| The first trimester | 1 (1.1%) | 1 (3.6%) | 0 (0%) | 0.074* |
| The second trimester | 14 (15.6%) | 7 (25.0%) | 7 (11.3%) | |
| The third trimester | 75 (83.3%) | 20 (71.4%) | 55 (88.7%) | |
| Gravidity | 0.679* | |||
| 1st pregnancy | 44 (49.0%) | 13 (46.4%) | 31 (50.0%) | |
| 2nd pregnancy | 25 (27.8%) | 7 (25.0%) | 18 (29.0%) | |
| 3rd pregnancy | 14 (15.6%) | 6 (21.4%) | 8 (12.9%) | |
| 4th pregnancy | 4 (4.4%) | 1 (3.6%) | 3 (4.8%) | |
| Multiple pregnancy (≥ 5 times) | 3 (3.3%) | 1 (3.6%) | 2 (3.2%) | |
| Parity | 0.151* | |||
| unipara | 58 (64.4%) | 21 (75.0%) | 38 (61.3%) | |
| 2nd para | 29 (32.2%) | 7 (25.0%) | 22 (35.5%) | |
| 3rd para | 2 (2.2%) | 0 (0%) | 2 (3.2%) | |
| History of abortion | 22 (24.4%) | 10 (35.7%) | 12 (19.4%) | 0.088Δ |
| Medical history | ||||
| Hypertension | 3 (3.3%) | 1(3.6%) | 2 (3.2%) | 0.678* |
| Hyperlipidemia | 10 (11.1%) | 4 (14.3%) | 6 (9.7%) | 0.377* |
| Hyperglycemia | 6 (6.7%) | 0 (0%) | 6 (9.7%) | 0.099* |
| AP/APIP history | 6 (6.7%) | 2 (7.1%) | 4 (6.5%) | 0.610* |
| Unhealthy lifestyle | 2 (2.2%) | 1(3.6%) | 1 (1.6%) | 0.528* |
| Etiology | 0.794* | |||
| HTG | 58 (64.4%) | 19 (67.9%) | 39 (62.9%) | |
| Biliary | 20 (22.2%) | 5 (17.9%) | 15 (24.2%) | |
| Others | 12 (13.3%) | 4 (14.3%) | 8 (12.9%) | |
| Complications before delivery | ||||
| ARDS | 12 (13.3%) | 8 (28.6%) | 4 (6.5%) | 0.007* |
| AKI | 10 (11.1%) | 6 (21.4%) | 4 (6.5%) | 0.046* |
| Shock | 3 (3.3%) | 2 (7.1%) | 1 (1.6%) | 0.678* |
| Acidosis | 3 (3.3%) | 3 (10.7%) | 0 (0%) | 0.028* |
| Severity | 0.12Δ | |||
| MAP | 22 (24.4%) | 4 (14.3%) | 18 (29.0%) | 0.186* |
| MSAP | 25 (27.8%) | 6 (21.4%) | 19 (30.7%) | 0.366* |
| SAP | 43 (47.8%) | 18 (64.3%) | 25 (40.3%) | 0.035* |
| Systematic complications in the course | ||||
| ARDS | 30 (33.3%) | 15 (53.6%) | 15 (24.2%) | 0.006Δ |
| AKI | 16 (17.8%) | 9 (32.1%) | 7 (11.3%) | 0.017* |
| Ketoacidosis/metabolic acidosis | 4 (4.4%) | 3 (10.7%) | 1 (1.6%) | 0.088* |
| Shock | 12 (13.3%) | 7 (25.0%) | 5 (8.1%) | 0.029* |
| Sepsis | 10 (11.1%) | 6 (21.4%) | 4 (6.5%) | 0.064* |
| Ileus | 7 (7.8%) | 3 (10.7%) | 4 (6.5%) | 0.67* |
| Intestinal fistula | 7 (7.8%) | 4 (14.3%) | 3 (4.8%) | 0.198* |
| Pleural/abdominal/pelvic effusion | 18 (20.0%) | 6 (21.4%) | 12 (19.4%) | 0.82Δ |
| Thrombogenesis | 6 (6.7%) | 3 (10.7%) | 3 (4.8%) | 0.37* |
| Hemorrhage | 4 (4.4%) | 3 (10.7%) | 1 (1.6%) | 0.088* |
BMI, body mass index; AP, acute pancreatitis; APIP, acute pancreatitis in pregnancy; HTG, hypertriglyceridemia; ARDS, acute respiratory distress syndrome; AKI, acute kidney injury; p-values marked by
Δ
were analyzed by Pearson chi-square tests and
*
were analyzed by Fisher's exact tests. p-Values were analyzed by Student t-tests marked by
#
and Mann–Whitney U-tests marked by a.